- Report
- January 2025
- 147 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- September 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- January 2025
- 143 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- March 2024
- 98 Pages
Global
From €3293EUR$3,450USD£2,759GBP
- Report
- April 2024
- 160 Pages
Asia Pacific
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2023
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- October 2023
- 175 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2023
- 77 Pages
France
From €3340EUR$3,500USD£2,799GBP
- Report
- January 2025
- 92 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2023
- 91 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- September 2024
- 260 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- September 2024
- 260 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Book
- December 2023
- 464 Pages

The Bioresorbable Material market within the Medical Devices industry is a rapidly growing sector. Bioresorbable materials are polymers that are designed to be absorbed by the body over time, allowing for the delivery of drugs and other treatments directly to the site of injury or disease. These materials are used in a variety of medical devices, such as stents, sutures, and drug delivery systems. They offer a number of advantages over traditional materials, including improved biocompatibility, reduced risk of infection, and improved patient comfort.
Bioresorbable materials are increasingly being used in a variety of medical applications, including orthopedic, cardiovascular, and dental. The market is expected to continue to grow as new applications are developed and the technology advances.
Some companies in the Bioresorbable Material market include Corbion, Evonik, Poly-Med, Inc., and PolyOne Corporation. Show Less Read more